[{"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0210-2015", "product_description": "PAPAVERINE HCL/PHENTOLAMINE/ALPROSTADIL, 21.82mg/0.91mg/45mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "43 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #:  20140722@16/1.7, discard date: 12/3/2014;  Lot #:  20140728@43/2, discard date: 12/3/2014."}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 151214-64, BUD: 5/31/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "MANGANESE CHL 0.1MG/ML PF,  10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1212-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "353 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03032015@4, 6/1/2015; 03312015@71, 6/29/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydroxocobalamin 5,000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1558-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050573"], "brand_name": ["SANDIMMUNE"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0109", "0078-0240", "0078-0241", "0078-0110"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["197552", "197553", "205175", "212810", "212844", "212957", "309632", "328160"], "spl_id": ["0b1732c5-125d-4878-867d-b4b9d6d2c50e"], "spl_set_id": ["5e5926a7-1de0-4b54-a5c0-286b6200ff82"], "package_ndc": ["0078-0240-61", "0078-0240-15", "0078-0241-61", "0078-0241-15", "0078-0109-61", "0078-0109-01", "0078-0110-22"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "93464", "recalling_firm": "Novartis Pharmaceuticals Corporation", "address_1": "1 Health Plz", "address_2": "", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0144-2024", "product_description": "SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22", "product_quantity": "6,997 bottles", "reason_for_recall": "Crystallization:  bottles of Sandimmune Oral Solution were determined to contain crystals", "recall_initiation_date": "20231122", "center_classification_date": "20231207", "report_date": "20231213", "code_info": "Lot #: FX001500, FX001582, Exp. 09/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89214", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one customer who may have further distributed the product.", "recall_number": "D-0327-2022", "product_description": "PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L", "product_quantity": "14 bulk lots (approximately 1,987,951 tablets each)", "reason_for_recall": "CGMP Deviations: failed stability results, inadequate laboratory investigations,", "recall_initiation_date": "20211129", "center_classification_date": "20220104", "termination_date": "20230224", "report_date": "20220112", "code_info": "Bulk Lots: 18K070, exp. date Nov-21; 19A046, exp. date Jan-22; 19C073, exp. date Mar-22; 19E014, exp. date  May-22; 19G039, exp. date Jul-22; 19K002, exp. date  Nov-22; 20A013, exp. date Jan-23; 20B050, exp. date Feb-23; 20C011, exp. date Mar-23; 20C049, exp. date Mar-23; 20F071, exp. date Jun-23; 20F072, exp. date Jun-23; 20G033, exp. date Jul-23; 20G041, exp. date Jul-23."}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040886"], "brand_name": ["PHENTERMINE HYDROCHLORIDE"], "generic_name": ["PHENTERMINE HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["55289-791"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENTERMINE HYDROCHLORIDE"], "rxcui": ["968766"], "spl_id": ["419b6194-7ef1-acbc-e063-6394a90a2315"], "spl_set_id": ["4000c00f-aa6c-4ea5-af0e-149dde3c74db"], "package_ndc": ["55289-791-07", "55289-791-14", "55289-791-15", "55289-791-21", "55289-791-28", "55289-791-30", "55289-791-60"], "original_packager_product_ndc": ["10702-026"], "upc": ["0355289791607"], "unii": ["0K2I505OTV"]}, "product_type": "Drugs", "event_id": "72941", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0574-2016", "product_description": "Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in  a) 7-count (NDC 55289-791-07), b) 14-count (NDC 55289-791-14), c) 28-count (NDC 55289-791-28), d) 30-count (NDC 55289-791-30), and e) 60-count (NDC 55289-791-60) bottles, Packaged by PD-RX Pharmaceuticals, INC Oklahoma City, OK 73127, MFG: KVK-TECH, INC Newtown, PA 18840.", "product_quantity": "1685 bottles", "reason_for_recall": "Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station", "recall_initiation_date": "20150721", "center_classification_date": "20160120", "termination_date": "20161223", "report_date": "20160127", "code_info": "Lot #: a) H14C80, Exp 08/16; I14G36, Exp 09/16; b) H14A86, Exp 07/16;  c) H14C83, Exp 08/16, K14A21, Exp 11/16; d) H14F25, Exp 08/16; e) L14C42, Exp 12/16.", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1168-2019", "product_description": "Prostaglandin 20 mcg/mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "23 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070434"], "brand_name": ["FUROSEMIDE"], "generic_name": ["FUROSEMIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-3294", "0054-4297", "0054-8297", "0054-4299", "0054-8299", "0054-4301", "0054-8301", "0054-3298"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FUROSEMIDE"], "rxcui": ["197730", "197731", "197732", "310429", "313988"], "spl_id": ["bae23091-065c-4127-a363-16d15dce1c5c"], "spl_set_id": ["9e493331-dddd-496e-abf8-61747fb67aba"], "package_ndc": ["0054-4297-31", "0054-4297-25", "0054-8297-25", "0054-4299-31", "0054-4299-25", "0054-8299-25", "0054-4301-29", "0054-4301-25", "0054-8301-25", "0054-3298-63", "0054-3294-50", "0054-3294-46"], "is_original_packager": [true], "upc": ["0300544301251", "0300544299251", "0300544297257", "0300543298637"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["7LXU5N7ZO5"]}, "product_type": "Drugs", "event_id": "76142", "recalling_firm": "Roxane Laboratories, Inc.", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0437-2017", "product_description": "Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio  43216, NDC 0054-4297-31.", "product_quantity": "6493 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.", "recall_initiation_date": "20161222", "center_classification_date": "20170123", "termination_date": "20171218", "report_date": "20170201", "code_info": "Lot# 660833A, Exp 08/31/18"}, {"status": "Terminated", "city": "Maple Grove", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64085", "recalling_firm": "Upsher Smith Laboratories, Inc.", "address_1": "6701 Evenstad Drive", "address_2": "N/A", "postal_code": "55369", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-127-2013", "product_description": "Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.", "product_quantity": "11,316 bottles", "reason_for_recall": "Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.", "recall_initiation_date": "20121210", "center_classification_date": "20130116", "termination_date": "20131119", "report_date": "20130123", "code_info": "Lot #: 310162, Exp 09/14"}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1103-2017", "product_description": "Make Up Perfect caramel (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03330, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 032302.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 130917, Exp 09/13/2017; 010818, Exp 08/01/2018."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0069-2020", "product_description": "LIDOcaine HCl 2% (PF) 100 mg/5 mL (20 mg/mL) 5 mL Fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487NDC 3321678315", "product_quantity": "4450 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-132-2014", "product_description": "HCG 3000IU, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "10 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020178"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0553"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807631", "1807632"], "spl_id": ["aca96e4a-a57b-47ac-bd60-e65c29e19743"], "spl_set_id": ["fbc01464-8885-4075-af41-911ffec5ae92"], "package_ndc": ["0338-0553-11", "0338-0553-18"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "65061", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Singapore", "recall_number": "D-623-2013", "product_description": "0.9% Sodium Chloride Injection, USP, 50 mL Mini-Bag Plus Container, Rx only, distributed by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0553-11", "product_quantity": "317,280 bags", "reason_for_recall": "Labeling Wrong Barcode;  It may display wrong product code reflecting  0.9% Sodium Chloride Injection , USP 100 mL in MINI-BAG Plus container instead of 50 mL.", "recall_initiation_date": "20130227", "center_classification_date": "20130627", "termination_date": "20150511", "report_date": "20130703", "code_info": "Lot: P293118; Exp Date: 10/13", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot #:20180216@10, BUD 5/17/2018; 20180129@25, BUD 04/29/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Biotin Suspension 10mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0636-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0669-2020", "product_description": "BAC 225MCG/ BUP 4.5MG/ CLON 9MCG/ MORP 3MG/ML ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@7 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0196-2018", "product_description": "Sermorelin Acetate 3 mg/ GHRP6 3 mg, Lyophilized Vial, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "157 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 06272017@4 BUD: 12/24/2017", "more_code_info": ""}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "109 vials", "code_info": "Lot #: Polidocanol 5% 30 mL: 20130319-I, Exp 6/19/2013; 20130326-H, Exp 6/26/2013; b) Polidocanol 1% 30 mL: 20130118-B, Exp 4/18/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Polidocanol Injection, all strengths and all presentations including a) Polidocanol 5% 30 mL, b) Polidocanol 1% 30 mL, c) Polidocanol 2% 30 mL, d) Polidocanol 3% 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-400-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "66637", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-66637-001", "product_description": "Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL single patient infusion vial packaged in 5 Units x 20 mL per carton, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.", "product_quantity": "70,450 vials", "reason_for_recall": "Presence of Particulate Matter: Visible particles embedded in the glass identified during a retain sample inspection.", "recall_initiation_date": "20131011", "center_classification_date": "20131104", "termination_date": "20141028", "report_date": "20131113", "code_info": "Lot #: 27-570-DJ, Exp 03/01/15"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "76 mL total", "code_info": "All lots distributed between November 2014 and May 2015;    01082015@34,7/7/2015; 12162014@46, 6/14/2015; 02032015@98, 8/2/2015; 02112015@79, 8/10/2015, 02192015@15, 8/18/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Alprostadil 40 mcg/ml Injection, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1439-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0296-2018", "product_description": "Liberator Medical Supply Catheter Insertion Tray, Sterile, Single Use Only. Distributed by: Liberator Medical Supply, INC. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "20,430 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDT1022E; Lots 17QB4402; 17TB1979", "more_code_info": ""}, {"status": "Terminated", "city": "Newark", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA022433"], "brand_name": ["BRILINTA"], "generic_name": ["TICAGRELOR"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-0776", "0186-0777"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TICAGRELOR"], "rxcui": ["1116635", "1116639", "1666332", "1666334"], "spl_id": ["716d1c45-09f7-4a1a-86a9-8f3c3243980e"], "spl_set_id": ["f7b3f443-e83d-4bf2-0e96-023448fed9a8"], "package_ndc": ["0186-0777-08", "0186-0777-60", "0186-0777-18", "0186-0777-39", "0186-0777-28", "0186-0776-60", "0186-0776-94"], "is_original_packager": [true], "nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["GLH0314RVC"]}, "product_type": "Drugs", "event_id": "77336", "recalling_firm": "AstraZeneca Pharmaceuticals, LP", "address_1": "587 Old Baltimore Pike", "address_2": "", "postal_code": "19702-1307", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA and Puerto Rico to physician offices.", "recall_number": "D-0958-2017", "product_description": "BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceuticals LP, Wilmington, DE  19850; By: AstraZeneca AB, SE-151 85 Sodertalje, Sweden, NDC 0186-0777-08.", "product_quantity": "40,368 bottles", "reason_for_recall": "Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.", "recall_initiation_date": "20170525", "center_classification_date": "20170711", "termination_date": "20180424", "report_date": "20170719", "code_info": "Lot # JB5047, Exp 10/19", "more_code_info": ""}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0039-2023", "product_description": "MITOMYCIN INJECTION 0.375 mg/mL SYR, 0.375 mg/mL solution, 1 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "185 syringes", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 60618, BUD: 5/6/2023; 66536, BUD: 7/8/2023"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "75 mL", "code_info": "Lot # 11-29-2016@27, Exp 5/20/2017; 01-25-2017@25, Exp 7/24/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0780-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "24 pellets", "code_info": "All lots distributed between November 2014 and May 2015    05062015@31, 11/2/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 62.5 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1652-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0031-2021", "product_description": "blumen ADVANCED HAND SANITIZER 70% ALCOHOL CONTENT, (ethyl alcohol 70% v/v) Packaged as a) 3.4 fl oz / 100 ml bottle, UPC 8 14266 02359 4, b) 7.5 fl oz / 221 ml bottle, UPC 8 14266 02362 4,  Distributed in USA and Canada By: 4e Brands Northamerica LLC, 17806 IH-10W, Suite 300, San Antonio, Texas, 78257, Made in Mexico.", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "Chemical Contamination and Subpotent Drug: Product tested to contain methanol as well as below the labeled claim for ethanol content.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "Lot #: a) 2141, Exp 04/40/23; 2879, Exp 04/23/23; 3005, Exp 05/08/23; b) 2911, Exp 04/23/23"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83840", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0122-2020", "product_description": "Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only, Manufactured for:  Torrent Pharma Inc., Basking Ridge, NJ 07920.  NDC 90 tablets: 13668-115-90; NDC 1000 tablets: 13668-115-10", "product_quantity": "39,432 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.", "recall_initiation_date": "20190919", "center_classification_date": "20191002", "report_date": "20191009", "code_info": "Count, lot, expiry: [90 count] Lot 4DU3E009, exp 12/31/2020; [1000 count] Lot 4DU3D018, exp 02/28/2021"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-520-2013", "product_description": "Cardec Drops,Antihistamine, Nasal Decongestant, 1 fl oz. bottle, OTC, Manufactured for: Macoven Pharmaceuticals, Magnolia, TX 77354 NDC 44183-604-30", "product_quantity": "26,536 bottles - 30 mL", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11DQ009 Exp. 03/13; Lot# 11JQ002 Exp. 08/13."}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83705", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.", "recall_number": "D-0145-2020", "product_description": "Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90", "product_quantity": "63,216 bottles", "reason_for_recall": "CGMP Deviation: Presence of dark brown discoloration on edges of tablets.", "recall_initiation_date": "20190904", "center_classification_date": "20191017", "termination_date": "20200212", "report_date": "20191023", "code_info": "Lot # PA218P008, PA218P009, Exp 04/2021"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62664", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distribution was nationwide and to Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-100-2013", "product_description": "Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,789,426/50-mcg. tablets", "reason_for_recall": "Subpotent; 9-month stability interval", "recall_initiation_date": "20120725", "center_classification_date": "20121221", "termination_date": "20131114", "report_date": "20130102", "code_info": "Lot HB23111 and HC23111"}, {"country": "United States", "city": "Waterford", "address_1": "6650 Highland Rd Ste 302", "reason_for_recall": "Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.", "address_2": "", "product_quantity": "1460 GM", "code_info": "Lots: 071916-1, Exp. 07/08/2018; 080516-1, 080516-2, Exp. 07/22/2018; 101216-1, 011917C-1, Exp. 09/15/2018;", "center_classification_date": "20180312", "distribution_pattern": "Nationwide in the USA.", "state": "MI", "product_description": "Sermorelin Acetate, powder, a) 1 GM-bottle (NDC58597-8092-1) b) 5 GM-bottle (NDC 58597-8092-2) c) 10 GM-bottle (NDC 58597-8092-4) API American Pharmaceutical Ingredients", "report_date": "20180321", "classification": "Class II", "openfda": {}, "recalling_firm": "American Pharmaceutical Ingredients LLC", "recall_number": "D-0592-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79420", "termination_date": "20191202", "more_code_info": "", "recall_initiation_date": "20180307", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91757", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-0469-2023", "product_description": "Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.", "product_quantity": "715,632 bottles", "reason_for_recall": "Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.", "recall_initiation_date": "20230223", "center_classification_date": "20230320", "termination_date": "20231128", "report_date": "20230322", "code_info": "Lot #114349, Exp. 05/2023; 117396, Exp. 09/2023; 120128, Exp. 11/2023; 114371, Exp. 06/2023; 123781, Exp. 02/2024."}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "120", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "HYDROmorphone HCI 0.2 mg/mL in 0.9% Sodium Chloride 50 mL fill in a 60 mL Monoject Syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC  45183-0933-75", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1326-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["SENNA SYRUP"], "generic_name": ["SENNOSIDES A AND B"], "manufacturer_name": ["SDA Laboratories, Inc."], "product_ndc": ["66424-562"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["SENNOSIDES A AND B"], "rxcui": ["702311"], "spl_id": ["29bbb628-c28a-9fbe-e063-6294a90a7a8b"], "spl_set_id": ["cfc6ab2f-5376-46fc-ac58-7dedd7010006"], "package_ndc": ["66424-562-08", "3664245620"], "is_original_packager": [true], "unii": ["1B5FPI42EN"], "upc": ["366424562082"]}, "product_type": "Drugs", "event_id": "80053", "recalling_firm": "RIJ Pharmaceutical LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0851-2018", "product_description": "SDA Senna Syrup (Sennosides 8.8mg), packaged in 8 FL. OZ. (236 mL) bottles, Distributed by SDA Laboratories 280 Railroad Avenue, Greenwich CT 06830, NDC 66424-562-08, UPC 366424562082", "product_quantity": "3537 bottles", "reason_for_recall": "CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.", "recall_initiation_date": "20180507", "center_classification_date": "20180608", "termination_date": "20230407", "report_date": "20180620", "code_info": "Lot #: 47070042, Exp. 09/18"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91670", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0436-2023", "product_description": "Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton:  60687-493-01; NDC Unit Dose: 60687-493-11.", "product_quantity": "422 cartons", "reason_for_recall": "Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.", "recall_initiation_date": "20230127", "center_classification_date": "20230306", "termination_date": "20240512", "report_date": "20230315", "code_info": "Lot 1009065, Exp 12/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-776-2015", "product_description": "Meloxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "16666 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0573-2017", "product_description": "TCA PEEL SOLUTION in all strengths including: 5%, 10%, 15%, 18%, and 20%, TCA 10%/LACTIC ACID 12%, TCA 6%/ LACTIC ACID12%, TCA 7%/SALICYLIC ACID 2% SOLUTION,  Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Nicardipine HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0834-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "1 Bag", "code_info": "Compounded on 05/29/15, Discard After: 06/12/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Fluorouracil 4250mg / D5W 285mL, Qty: 1 285 mL Bag, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1203-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Huntsville", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70598", "recalling_firm": "Qualitest Pharmaceuticals", "address_1": "120 Vintage Dr NE", "address_2": "N/A", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0411-2015", "product_description": "PROMETHAZINE DM SYRUP (Promethazine Hydrochloride, USP and Dextromethorphan Hydrobromide, USP), EACH 5 ml (ONE TEASPOONFUL) CONTAINS:  Promethazine Hydrochloride 6.25 mg, Dextromethorphan Hydrobromide 15 mg, alcohol 7%,  ONE PINT (574 mL), Rx only, Manufactured for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC:  0603-1586-58.", "product_quantity": "972 bottles", "reason_for_recall": "Presence of Foriegn Substance: Plastic cap closure particulates may be present in the product.", "recall_initiation_date": "20150223", "center_classification_date": "20150312", "termination_date": "20160712", "report_date": "20150318", "code_info": "Lot #:  0000001099; Exp. 03/16"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0573-2021", "product_description": "Proair HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation With Dose Counter 200 Metered Inhalation 8,5 g Net Contents Rx only NDC 59310-579-22 Mktd by: Teva Respiratory, LLC Horsham, PA 19044 Mfd by: IVAX Pharmaceuticals Ireland Waterford, Ireland", "product_quantity": "26895 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "DAF02A"}, {"status": "Terminated", "city": "Stamford", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["BETADINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Atlantis Consumer Healthcare, Inc."], "product_ndc": ["67618-153"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["797730", "798176"], "spl_id": ["4357dde4-a121-3be4-e063-6394a90af3c8"], "spl_set_id": ["0707b259-52a4-4ae6-b176-d093865906e7"], "package_ndc": ["67618-153-01", "67618-153-03"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "78229", "recalling_firm": "Purdue Pharma, LP", "address_1": "1 Stamford Forum", "address_2": "N/A", "postal_code": "06901-3516", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0070-2018", "product_description": "Betadine Solution Swabstick Povidone-Iodine Solution USP, 10% Dist.by: Purdue Products LP. Stamford, CT 06901-3431 NDC 67618-153-01", "product_quantity": "3997 swabsticks", "reason_for_recall": "Subpotent Drug: The laminate used to make the pouches was reversed such that the aluminum layer was in contact with the product causing an exothermic reaction between the free iodine and the aluminum.", "recall_initiation_date": "20171005", "center_classification_date": "20171103", "termination_date": "20200124", "report_date": "20171115", "code_info": "Lots: 62823 Exp. 12/31/18; 64304 Exp. 05/31/2019; 64711 Exp. 08/31/2019; 65915 Exp. 12/31/2019"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1403-2012", "product_description": "Loxitane Capsules, Loxapine Succinate Capsules,  10mg base, 100 count bottle, Rx only,   Watson Laboratories Inc., Corona, CA 92880 NDC #  52544-495-01", "product_quantity": "7,262 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot # 22478A"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-265-2014", "product_description": "Sermorelin 3mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "71 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-645-2015", "product_description": "Droperidol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211143"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE ER TABLETS"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-501", "68001-500", "68001-502", "68001-503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["041e82dd-5b9b-11e0-e063-6294a90aca1a"], "spl_set_id": ["6588d77c-090f-4722-9c91-437887d4624a"], "package_ndc": ["68001-500-00", "68001-500-03", "68001-500-08", "68001-501-00", "68001-501-03", "68001-501-08", "68001-502-00", "68001-502-03", "68001-502-08", "68001-503-00"], "is_original_packager": [true], "upc": ["0368001500005"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "91528", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0269-2023", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories", "product_quantity": "(a) 6670 100-count (b) 2666 500-count bottles", "reason_for_recall": "Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer  which included lots that were packaged for BluePoint Laboratories.", "recall_initiation_date": "20230111", "center_classification_date": "20230215", "termination_date": "20240512", "report_date": "20230222", "code_info": "Lots: (a) 21143211, EXP 03/31/2023; (b) 21143185, 21143193, EXP 02/28/2023"}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78227", "recalling_firm": "Banner Pharmacy Services, LLC", "address_1": "7300 W Detroit St", "address_2": "N/A", "postal_code": "85226-2410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0025-2018", "product_description": "Succinylcholine 200 mg/10 mL Syringe, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226,  NDC 7025088801", "product_quantity": "2792 syringes", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20171010", "center_classification_date": "20171023", "termination_date": "20180809", "report_date": "20171101", "code_info": "Lot #: 071917S5 Exp 10/17/2017; , 072717S7, Exp 10/25/2017; 080817S3, Exp 11/6/2017;  082317S6, Exp 11/21/2017;  082417S6, Exp 11/22/2017; 082517S3, Exp 11/23/2017."}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0631-2016", "product_description": "MORPHINE 10MG/ML in NS, Packaged in a) 150ML Homepumps and b) 250ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 5 Bags, b) 4 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 25-Sep-15, b) 30-Sep-15"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0079-2015", "product_description": "Dihydroergotamine mesylate 1 mg/mL injection solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "510 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06162014@34, Exp 9/14/2014; 08142014@39, Exp 11/12/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0286-2020", "product_description": "S-TESTOSTERONE CYP 200MG/ML MDV In SESAME OIL, Rx Only, a) 5ML, b) 10ML, c) 13 ML glass vial, Red Mountain Compounding Rx", "product_quantity": "129x 5ml, 10ml, 13ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S02252019DH@07, Exp 8/25/19; S03202019DT@02, EXP, 8/25/19;    S03212019DT@02, EXP, 9/21/19; S04232019DT@06, EXP, 10/23/19;    S05232019DT@06, EXP, 11/23/19; S05152019DH@12, EXP, 11/15/19;    S05242019DT@03, EXP, 11/24/19; 05152019DH@12, EXP, 11/15/19;    S06262019DT@02, EXP, 12/26/19; S07032019DT@12, EXP, 1/3/20;    S07132019DT@03, EXP, 1/13/20; S07162019DT@01, EXP, 1/16/20;    S07262019DH@06, EXP, 1/26/20; S05152019DH@12, EXP, 11/15/19;"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1457-2022", "product_description": "MUCINEX FASTMAX CAPLETS COLD FLU 4CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 903372", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78791", "recalling_firm": "SHISEIDO AMERICA INC.", "address_1": "366 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1411", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0218-2018", "product_description": "Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, NDC 58411-256-60", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.", "recall_initiation_date": "20171214", "center_classification_date": "20180112", "termination_date": "20210624", "report_date": "20180124", "code_info": "SKU#: 95284"}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78462", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed throughout United States.", "recall_number": "D-0088-2018", "product_description": "Extra Strength Naturally HL Hemorrhoid Numbing Spray with Lidocaine, (lidocaine HCL 4%), 1/2 oz Spray (NDC 69804-015-08), 1 oz Spray (NDC 69804-015-07), 2 oz Spray (NDC 69804-015-01) and 4 oz Spray (NDC 69804-015-04) bottles, Manufactured by Pain Relief Naturally, www.Naturally HL.com", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: inadequate manufacturing control processes", "recall_initiation_date": "20171103", "center_classification_date": "20171121", "termination_date": "20190114", "report_date": "20171129", "code_info": "All batches and lots, exp 10/17/2018. Not all batches were assigned lot numbers"}, {"status": "Completed", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090480"], "brand_name": ["MUPIROCIN"], "generic_name": ["MUPIROCIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-180"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["MUPIROCIN"], "rxcui": ["106346"], "spl_id": ["1560b587-27d8-49cd-9b43-21cc6c30afc1"], "spl_set_id": ["ff7428fb-9ce9-4743-b58c-01a05424a57a"], "package_ndc": ["68462-180-22"], "is_original_packager": [true], "nui": ["N0000175515", "N0000175516"], "pharm_class_epc": ["RNA Synthetase Inhibitor Antibacterial [EPC]"], "pharm_class_moa": ["RNA Synthetase Inhibitors [MoA]"], "unii": ["D0GX863OA5"]}, "product_type": "Drugs", "event_id": "95279", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States.", "recall_number": "D-0660-2024", "product_description": "Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.", "product_quantity": "2,031,480 ointments", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240830", "center_classification_date": "20240920", "report_date": "20241002", "code_info": "Lot #: 19223615, 19223537, 19223544,19223568, 19223593,19223641, Exp. Date 08/2024;  19224055,19224281, 19224307, 19224321,  19224341, 19224467, Exp. Date 09/2024;  19224525, 19224542, 19224560,19224580, Exp. Date 10/2024; 19224990, 19224998, 19225014, 19225033, 19225293, 19225304, 19225320, 19225349, 19225367, 19225379,  19225401, Exp. Date 11/2024; 19230115, 19230123, 19230132, 19230137, 19230167,  19230170, Exp. Date 12/2024; 19230572, 19230607, 19230614, 19230628, 19230631, Exp. Date 1/2025; 19230874, 19230925,19230941, 19230957, 19230976,19231232, 19231238,  19231282,19231285, Exp. Date 02/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1400-2019", "product_description": "Sn-DMSA solution, Store Frozen, Not for Direct Injection, Synthetopes, Inc.", "product_quantity": "3 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA202438"], "brand_name": ["FAMCICLOVIR"], "generic_name": ["FAMCICLOVIR"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-706", "31722-707", "31722-708"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMCICLOVIR"], "rxcui": ["198382", "199192", "199193"], "spl_id": ["2b438049-f70c-5388-e063-6394a90af892"], "spl_set_id": ["08c58224-5920-4853-8c59-ec5fbb66c2f6"], "package_ndc": ["31722-706-30", "31722-706-60", "31722-706-01", "31722-706-05", "31722-706-10", "31722-707-30", "31722-707-60", "31722-707-01", "31722-707-05", "31722-707-10", "31722-708-30", "31722-708-60", "31722-708-01", "31722-708-05", "31722-708-10"], "is_original_packager": [true], "nui": ["N0000020060", "N0000180187", "N0000175459"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "unii": ["QIC03ANI02"]}, "product_type": "Drugs", "event_id": "78811", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0415-2018", "product_description": "Famciclovir Tablets, 500 mg, 30-count bottles, Rx Only, Manufactured For: Camber Pharmaceuticals. Inc. Piscataway, NJ 08854 By: HETERO, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar-509 301, India. NDC 31722-708-30", "product_quantity": "8,436 bottles", "reason_for_recall": "Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.", "recall_initiation_date": "20171222", "center_classification_date": "20180215", "termination_date": "20200205", "report_date": "20180221", "code_info": "Lot # FMC17039, Exp 07/2019.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0651-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Climate Adaptation Cold & Damp, 2 fl. oz. (59 mL),  King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955528425, NDC 57955-0170-2", "product_quantity": "15 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 071316G Exp. 07/19"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80251", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0854-2018", "product_description": "HYDROmorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride, 1 mL Total Volume in 3 mL syringe, Rx, PharMEDium Services, LLC, Dayton, NJ", "product_quantity": "2,800 syringes", "reason_for_recall": "Superpotent and Subpotent", "recall_initiation_date": "20180605", "center_classification_date": "20180608", "termination_date": "20190206", "report_date": "20180620", "code_info": "Lot numbers: 180820005D, exp 6/21/2018; 180990007D, exp 7/8/2018; and 181000020D, exp 7/9/2018"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66206", "recalling_firm": "University Compounding Pharmacy", "address_1": "1875 3rd Avenue", "address_2": "N/A", "postal_code": "92101", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1021-2013", "product_description": "Testosterone CYP (Sesame Oil) 200mg/mL Injection, 10 mL Vial, University Compounding Pharmacy, 855-398-1800.", "product_quantity": "965.50 mL", "reason_for_recall": "Lack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.", "recall_initiation_date": "20130906", "center_classification_date": "20130912", "termination_date": "20140121", "report_date": "20130918", "code_info": "Lot #s: 474323, Exp 9/13/2013; 498616, Exp 9/25/2013; 475475, Exp 9/26/2013.", "more_code_info": ""}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64103", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-150-2013", "product_description": "Carisoprodol Tablets, USP, 350 mg, packaged in a) 500-count tablets per bottle (NDC 0143-1176-05) and b) 1000-count tablets per bottle (NDC 0143-1176-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.", "product_quantity": "8,585 bottles", "reason_for_recall": "Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.", "recall_initiation_date": "20121207", "center_classification_date": "20130205", "termination_date": "20141218", "report_date": "20130213", "code_info": "Lot #: 69364A, 69365A, and 69365B, Exp 10/15", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "T.C.A 30% Acid Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0455-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92690", "recalling_firm": "New England Life Care, Inc. dba Advanced Compounding Solutions", "address_1": "4 Constitution Way Ste L", "address_2": "N/A", "postal_code": "01801-1042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0927-2023", "product_description": "PHENYLephrine HCl 10mg added to 0.9% Sodium Chloride 250mL, 250 mL IV Bag @60 Total volume), RX only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042, NDC: 71546-450-25;", "product_quantity": "82 Bags", "reason_for_recall": "CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.", "recall_initiation_date": "20230710", "center_classification_date": "20230719", "termination_date": "20231204", "report_date": "20230726", "code_info": "Lot # 20230524-6FBB77, Exp 21OCT2023", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89864", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0755-2022", "product_description": "Accuretic (quinapril HCl/hydrochlorothiazide) Tablets 10 mg/12.5 mg 90 tablets bottle, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0222-23", "product_quantity": "160 bottles", "reason_for_recall": "CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.", "recall_initiation_date": "20220321", "center_classification_date": "20220406", "termination_date": "20240828", "report_date": "20220413", "code_info": "Lot EA6686; Exp. 04/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95588", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0037-2025", "product_description": "Morphine Sulfate Extended-Release Tablets 30 mg,  100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.", "product_quantity": "532 100-count bottles", "reason_for_recall": "Failed Impurities/Degradation Specification", "recall_initiation_date": "20241022", "center_classification_date": "20241104", "report_date": "20241113", "code_info": "Lot# FG13996, Exp 09/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Fountain Run", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77601", "recalling_firm": "Apace KY LLC", "address_1": "12954 Fountain Run Rd", "address_2": "N/A", "postal_code": "42133-7914", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "KY", "recall_number": "D-1036-2017", "product_description": "Cyclobenzaprine HCl Tablets, USP, 5 mg, 50 Tablets (5x10) Unit Dose Cartons, Rx Only, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0190-15", "product_quantity": "N/A", "reason_for_recall": "Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg", "recall_initiation_date": "20170619", "center_classification_date": "20170731", "termination_date": "20180504", "report_date": "20170809", "code_info": "Lot:  16710, exp 07/2018"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CHOLECALCIFEROL, Capsule, 5000 units may be potentially mislabeled as     SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD70629_16, EXP: 5/29/2014;  CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W003540, EXP: 6/21/2014;  THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree: AD52993_16, EXP: 5/20/2014.", "address_2": "", "product_quantity": "300 Capsules", "code_info": "CHOLECALCIFEROL, Capsule, 5000 units has the following codes    Pedigree: AD70629_19, EXP: 5/29/2014;  Pedigree: W003541, EXP: 6/21/2014;  Pedigree: AD52993_22, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHOLECALCIFEROL, Capsule, 5000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 0904598660", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-487-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80790", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.", "recall_number": "D-0101-2019", "product_description": "Metformin Hydrochloride Extended Release Tablets 1000 mg, 90-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL, 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 , NDC 00591-2412-19", "product_quantity": "N/A", "reason_for_recall": "Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.", "recall_initiation_date": "20180806", "center_classification_date": "20181025", "termination_date": "20200213", "report_date": "20181031", "code_info": "Lot #: 1240400A, Exp 05/2019; 1293935M, Exp 12/2019"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078787"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["NorthStar Rx LLC"], "product_ndc": ["16714-661", "16714-662", "16714-663"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["2f6c168b-aaf3-4a6a-b8a0-5be6b5f81d7e"], "spl_set_id": ["f7c1fd34-d615-43a2-8989-898fe11f90df"], "package_ndc": ["16714-661-01", "16714-661-02", "16714-661-03", "16714-662-01", "16714-662-02", "16714-662-03", "16714-663-01", "16714-663-02"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"], "upc": ["316714662015"]}, "product_type": "Drugs", "event_id": "69807", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "6 Wheeling Road", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0330-2015", "product_description": "Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.", "product_quantity": "24,816 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints of empty capsules received.", "recall_initiation_date": "20141017", "center_classification_date": "20150106", "termination_date": "20160523", "report_date": "20150114", "code_info": "Lot #: GESB14011-A, Exp 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dunn", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93418", "recalling_firm": "Family Medical Supply Inc", "address_1": "2011 W Cumberland St", "address_2": "N/A", "postal_code": "28334-4447", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0106-2024", "product_description": "Oxygen, Compressed USP, UN 1072, packaged in cylinders labeled as Size: a) C; b) D; c) E; d) H; e) M; f) M6, Rx only, Family Medical Supply, 2011 W Cumberland St. Dunn, NC 28334.", "product_quantity": "26,657 Cylinders", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20231109", "center_classification_date": "20231116", "termination_date": "20250808", "report_date": "20231122", "code_info": "All lots manufactured and distributed May 10, 2023, through October 31, 2023."}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["POLYVINYL ALCOHOL"], "generic_name": ["POLYVINYL ALCOHOL"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-678"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL"], "rxcui": ["142004"], "spl_id": ["334b3c0f-7061-b4b8-e063-6394a90aee9a"], "spl_set_id": ["f18b61da-4033-341a-e053-2a95a90a8ebf"], "package_ndc": ["50268-678-15"], "is_original_packager": [true], "unii": ["532B59J990"]}, "product_type": "Drugs", "event_id": "96032", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0176-2025", "product_description": "Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-678-15", "product_quantity": "0", "reason_for_recall": "LABELING: LABEL MIX-UP", "recall_initiation_date": "20241218", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lot #: 0160, Exp. Date April 26 2026", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040302"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1323", "0409-4903", "0409-4904", "0409-9137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1012066", "1012068"], "spl_id": ["b386f7fc-ec89-4d73-aba6-2019a9cb1d4a"], "spl_set_id": ["ad1ef0a8-88db-4648-c098-d009eaeb4e5b"], "package_ndc": ["0409-4903-11", "0409-4903-34", "0409-4904-11", "0409-4904-34", "0409-1323-15", "0409-1323-05", "0409-9137-11", "0409-9137-05"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "93124", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico.  The products were not distributed to government accounts or foreign consignees.", "recall_number": "D-0101-2024", "product_description": "1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11", "product_quantity": "21,390 vials", "reason_for_recall": "Presence of Particulate Matter: identified as glass.", "recall_initiation_date": "20231002", "center_classification_date": "20231109", "termination_date": "20250214", "report_date": "20231115", "code_info": "Lot#: 42290DK, Exp. 6/1/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0786-2019", "product_description": "Dr. King's SafeCare Rx Gout Symptom Relief, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955002123, NDC 57955-0021-2", "product_quantity": "245 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 091216G Exp. 09/19; 032216F Exp. 03/19"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0423-2020", "product_description": "Altaire Sterile Eye Wash, 15 mL (1/2 fl oz), Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931  NDC 59390-175-13", "product_quantity": "48,542 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17241 8/20 8/24/2017   17322 10/20 12/21/2017   18169 7/20 7/30/2018   19052 2/22"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0247-2017", "product_description": "Amino Acid Recover Eaze (50 ML), Phenylaline (L) 8 mg/ml + Tyrosine (L) 0.45 mg/ml + L-Taurine 0.7 mg/ml.  Compounded by Tri-Coast Pharmacy.", "product_quantity": "105 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp Date): 06072016C (11/15/2016), 08162016E (09/08/2016)."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup :SELENIUM, Tablet, 50 mcg may have potentially been mislabeled as the following drug:  guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD56917_13, EXP: 5/21/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "SELENIUM, Tablet, 50 mcg has the following codes:   Pedigree: AD56939_1, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SELENIUM, Tablet, 50 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904316260.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1029-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "24 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  12182014@21, 6/16/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 4 mg, Sterile Pellet, The Compounding Pharmacy of America, Inc., Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1473-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1357-2019", "product_description": "Biscolax Laxative (Bisacodyl, USP 10 mg), a) 12 suppositories per carton, NDC: 0904-5058-12, b) 100 suppositories per carton, NDC: 0904-5058-60, Distributed by Major Pharmaceuticals Inc., Livonia MI 48152.", "product_quantity": "391,404 cartons", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: a) 17E004; 17E033, Exp. 05/2019; 17F019, Exp. 06/2019; 17G017, Exp. 07/2019; 17K009; 17K030; Exp. 10/2019, 17M006; 17M028, Exp. 12/2019; 18A029, Exp. 01/2020; 18C037, Exp. 03/2020; 18E002, Exp. 05/2020; 18F003; 18F013, Exp. 06/2020; 18G002; 18G016, Exp. 07/2020; 18H031, Exp. 08/2020; 18J004, 09/2020; 18L008; 18L012, Exp. 11/2020; 19A008, Exp. 01/2021.    b) 17E005; 17E027, Exp. 05/2019; 17K025, Exp. 10/2019; 17M006, Exp. 12/2019; 18A014, Exp. 01/2020; 18B039, Exp. 02/2020; 18C037, Exp. 03/2020; 18D033, Exp. 04/2020; 18E025, Exp. 05/2020; 18F013; 18F018, Exp. 06/2020; 18G003, Exp. 07/2020; 18H012; 18H014, Exp. 08/2020; 18J026, Exp. 09/2020; 18L009, Exp. 11/2020; 18M014, Exp. 12/2020; 19A021, Exp. 01/2021; 19B001; 19B002, Exp. 02/2021."}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97251", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0568-2025", "product_description": "Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle, NDC 61919-0482-60, c) 90-count bottle, NDC 61919-0482-90;   Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037,", "product_quantity": "875 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250307", "center_classification_date": "20250804", "report_date": "20250813", "code_info": "Lot #:  a) 15AU2420, 01JY2407, 04OC2411, Exp 01/31/2027; 12SE2418, 24OC2424, 20NO2416, Exp 03/31/2027; 21AU2313, 21JY2311, 05JY2313, Exp Date 01/31/2026 b) 13OC2310, 05SE2304, 04AU2306, 21JY2317, 12JY2306, Exp 01/31/2026; 11JY2416, 28JU2414, 19AU2412, 02AU2409, Exp 01/31/2027; 11SE2416, 24OC2425, Exp 03/31/2027;  c) 23AU2317, 21AU2314, Exp 01/31/2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020622"], "brand_name": ["COPAXONE"], "generic_name": ["GLATIRAMER ACETATE"], "manufacturer_name": ["Teva Neuroscience, Inc."], "product_ndc": ["68546-317", "68546-325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["GLATIRAMER ACETATE"], "rxcui": ["1111641", "1111642", "1487361", "1487363"], "spl_id": ["5a691b1f-367f-4635-a7d6-0111361a2dbb"], "spl_set_id": ["aa88f583-4f5f-433b-80b4-1f4c9fb28357"], "package_ndc": ["68546-317-00", "68546-317-30", "68546-325-06", "68546-325-12"], "is_original_packager": [true], "unii": ["5M691HL4BO"]}, "product_type": "Drugs", "event_id": "62241", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1442-2012", "product_description": "Copaxone (glatiramer acetate injection),  20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30", "product_quantity": "6,647 cartons", "reason_for_recall": "Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.", "recall_initiation_date": "20120518", "center_classification_date": "20120803", "termination_date": "20130411", "report_date": "20120815", "code_info": "Lot number X05011, Exp 08/13", "more_code_info": ""}, {"status": "Ongoing", "city": "Lexington", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["LICEOUT"], "generic_name": ["PIPERONYL BUTOXIDE AND PYRETHRUM EXTRACT"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-124"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["PIPERONYL BUTOXIDE", "PYRETHRUM EXTRACT"], "rxcui": ["283217", "2599624"], "spl_id": ["261c741f-1376-8ce1-e063-6394a90a92a0"], "spl_set_id": ["37805f32-b71f-4f8a-a4a3-2d26a8cbf564"], "package_ndc": ["53247-124-01", "53247-124-02"], "is_original_packager": [true], "unii": ["LWK91TU9AH", "ZUM06L90GV"]}, "product_type": "Drugs", "event_id": "95823", "recalling_firm": "Neogen Corporation", "address_1": "1847 Mercer Rd Ste A", "address_2": "", "postal_code": "40511-1001", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.", "recall_number": "D-0074-2025", "product_description": "LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526.  NDC: 53247-124-02", "product_quantity": "8,328 jugs", "reason_for_recall": "CGMP violations.", "recall_initiation_date": "20241008", "center_classification_date": "20241127", "report_date": "20241204", "code_info": "Lot, expiry:  LO09530, exp 11/3/2024; LO13412, exp 12/7/2024; LO10263, exp 1/26/2025; LO11303, exp 5/10/2025; LO12153, exp 8/3/2025; LO12483, exp 9/5/2025; LO13183, exp 11/14/2025; LO106024, exp 2/29/2026; LO108624, exp 3/26/2026; LO110224, exp 4/11/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0246-2017", "product_description": "Amino Energy Cocktail (30 ML),  (Methionine (L) 12.5 mg/Inositol 25 mg/Choline Chloride 25 mg/Methylcobalamin 300 mcg/Carnitine (L) 125 mg/Thiamine HCL 50 mg/Riboflavin-5-Phosphate Sod 5 mg/Niacinamide 20 mg/Pyridoxine HCL 2 mg/Folic Acid 2 mg/Ascorbic Acid 50 mg/Chromium Picolinate 200 mcg/Glutamine (L) 30 mg/Lidocaine HCL 10 mg/mL). Compounded by Tri-Coast Pharmacy.", "product_quantity": "59 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.      Known lot codes (Exp Date): 06012016A (11/28/2016), 07282016A   (12/31/2016)."}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078536"], "brand_name": ["CARBIDOPA AND LEVODOPA"], "generic_name": ["CARBIDOPA AND LEVODOPA"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-517", "62756-518", "62756-519", "62756-985"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBIDOPA", "LEVODOPA"], "rxcui": ["197443", "197444", "197445"], "spl_id": ["d77ed25a-588d-4d22-855f-f93ba5b4003c"], "spl_set_id": ["829c35f9-ace0-11dd-8800-f3e252b43544"], "package_ndc": ["62756-517-83", "62756-517-88", "62756-517-08", "62756-517-13", "62756-517-18", "62756-518-83", "62756-518-88", "62756-518-08", "62756-518-13", "62756-518-18", "62756-519-83", "62756-519-88", "62756-519-08", "62756-519-13", "62756-519-18", "62756-985-01", "62756-985-02"], "is_original_packager": [true], "upc": ["0362756517882", "0362756519886", "0362756518889"], "nui": ["N0000175754", "N0000175755", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "46627O600J"]}, "product_type": "Drugs", "event_id": "76230", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0455-2017", "product_description": "Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd.  Halol-Baroda Highway, Halol-389 350 Gujarat, India.", "product_quantity": "8,537 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170112", "center_classification_date": "20170202", "termination_date": "20180629", "report_date": "20170208", "code_info": "a) JKP5530A Exp. 12/17, JKP3991A   Exp. 11/17,  JKR6535A  Exp. 07/18  b) JKP5529A  Exp. 11/17", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065061"], "brand_name": ["CLINDAMYCIN HYDROCHLORIDE"], "generic_name": ["CLINDAMYCIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-692", "63304-693"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLINDAMYCIN HYDROCHLORIDE"], "rxcui": ["197518", "284215"], "spl_id": ["339366d4-2060-1c29-e063-6394a90a1cb7"], "spl_set_id": ["1dbd8448-c1e5-46df-8060-50ef82380445"], "package_ndc": ["63304-692-01", "63304-692-05", "63304-692-77", "63304-692-03", "63304-693-16", "63304-693-01", "63304-693-03", "63304-693-05", "63304-693-77", "63304-693-11", "63304-693-62"], "is_original_packager": [true], "upc": ["0363304693010"], "unii": ["T20OQ1YN1W"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0568-2021", "product_description": "CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP,150MG 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-692-01", "product_quantity": "223 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AB77104"}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0965-2016", "product_description": "Thin and Slim Burn Fat Now Dietary Supplement packaged in 90 capsule containers.  http://www.secretsofherbs.com.  Made in the USA.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "unknown"}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92348", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Missouri only", "recall_number": "D-0643-2023", "product_description": "VANComycin 2.5 g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-224-50", "product_quantity": "54 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230502", "center_classification_date": "20230518", "report_date": "20230524", "code_info": "Lot #: AC-016649, Exp. Date 07/01/2023"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "175", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Ketamine 20 mg/mL in 0.9% Sodium Chloride, 50 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0925-41", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1323-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1107-2020", "product_description": "Acne Off,  Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0902-2022", "product_description": "Sermorelin Acetate Lyophilized powder for reconstitution 9 mg Per Multi-Dose Vial, Rx Only,  Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0059-00", "product_quantity": "4459 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24115 BUD: 12/15/2022; A24203 BUD: 01/03/2023; A24106 BUD: 01/06/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020356"], "brand_name": ["NISOLDIPINE"], "generic_name": ["NISOLDIPINE"], "manufacturer_name": ["Prasco Laboratories"], "product_ndc": ["66993-472", "66993-473", "66993-475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NISOLDIPINE"], "rxcui": ["763519", "763589", "790489"], "spl_id": ["a999e1d0-199c-4631-8a51-8dc27e05f3ab"], "spl_set_id": ["8a5fb6a2-9fae-4872-8c5c-0f1ba03a57cb"], "package_ndc": ["66993-472-02", "66993-473-02", "66993-475-02", "59630-501-10"], "is_original_packager": [true], "nui": ["N0000175421", "M0006414", "N0000000069", "N0000178477"], "pharm_class_epc": ["Dihydropyridine Calcium Channel Blocker [EPC]"], "pharm_class_cs": ["Dihydropyridines [CS]"], "pharm_class_moa": ["Calcium Channel Antagonists [MoA]"], "pharm_class_pe": ["Decreased Blood Pressure [PE]"], "unii": ["4I8HAB65SZ"], "upc": ["359630501105"]}, "product_type": "Drugs", "event_id": "71828", "recalling_firm": "Shionogi Inc.", "address_1": "5770 Shiloh Rd", "address_2": "N/A", "postal_code": "30005-8408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1284-2015", "product_description": "Nisoldipine Extended Release Tablets, 17 mg, packaged as a)  Sular (nisoldipine) Extended Release tablets, 100-count bottle (NDC 59630-501-10, UPC 3 59630 50110 5), Manufactured for: Shionogi, Inc., Florham Park, NJ 07932; and b) Nisoldipine Extended Release tablets, 100-count bottle (NDC 66993-473-02, UPC 3 6693 47302 4), Manufactured for: Prasco Laboratories, Mason, OH  45040; Rx only; Manufactured by: Aenova France SAS, 38291 Saint Quentin-Falavier, France.", "product_quantity": "a) 483 bottles; b) 5,631 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20150724", "center_classification_date": "20150804", "termination_date": "20160414", "report_date": "20150812", "code_info": "Lot #: a) 8803472, Exp 03/16; b) 8803473, Exp 03/16"}, {"status": "Ongoing", "city": "Redondo Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["KinderFarms, LLC"], "product_ndc": ["82673-097"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["52688f1c-e600-4bc0-95ee-24086710e70e"], "spl_set_id": ["f33db02a-58f4-41a5-8f1f-4ec64d17f5a1"], "package_ndc": ["82673-097-04", "8500018057"], "is_original_packager": [true], "upc": ["0850001805728", "850001805728"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "93448", "recalling_firm": "KINDER FARMS LLC", "address_1": "409 N Pacific Coast Hwy", "address_2": "", "postal_code": "90277-2870", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0142-2024", "product_description": "KinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4 FL OZ (118 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-097-04, UPC 850001805728.", "product_quantity": "591,684 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20231113", "center_classification_date": "20231206", "report_date": "20231213", "code_info": "Lot: CJ70900, CJ76796, Exp: 8/2024; CJ77051, Exp: 09/2024; WK02998, WK02997, WK04390, WK02999, Exp: 10/2024; WK03716, Exp:12/2024; WK05150, WK05151, WK07174, Exp:02/2025; WK05539, WK06534, Exp: 03/2025; WK10259, WK23040, Exp: 04/2025; WK27455, Exp: 08/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-145-2014", "product_description": "HCG 5,000U, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2188 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0415-2020", "product_description": "Altacaine (Tetracaine Hydrochloride) Ophthalmic Solution, USP, 0.5%, 15 mL, Rx only, Mfd. by: Altaire Pharmaceuticals Inc. Aquebogue, NY 111931, NDC 59390-181-13", "product_quantity": "306,479 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17205 07/19 08/31/2017   17206 07/19 09/13/2017   17271 09/19 11/08/2017   18003 01/20 03/06/2018   18097 04/20 05/11/2018   18166 07/20 07/26/2018   18227 09/20 10/05/2018   18246 10/20 11/16/2018   18317 12/20 12/18/2018   19080 03/21 04/22/2019   19106 04/21"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Oxytocin all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0821-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1211-2019", "product_description": "Diltiazem 250 mg in NS 250 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "1475 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: EA161906 Exp. 4/16/2019; EA181906 Exp. 4/18/2019; EA231907 Exp. 4/23/2019; EA241907 Exp. 4/24/2019; EB061907 Exp. 5/7/2019; EB201907 Exp. 5/21/2019; EC181909 Exp. 6/16/2019"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "13 vials", "code_info": "Lot #: a) Progesterone 100 mg/mL 10 mL: 20130306-E, Exp 6/6/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Progesterone Injection, all strengths and all presentations including a) Progesterone 100 mg/mL 10 mL, 30 mL b) Progesterone 50 mg/mL 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-402-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-147-2014", "product_description": "HCG 5000iu kit, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "222 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64879", "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "address_1": "1850 Whitney Mesa Dr", "address_2": "Suite 180", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-407-2013", "product_description": "Sodium Bicarbonate Injection, all strengths and all presentations including: a) Sodium Bicarb 4.2% 5 mL PF, b) Sodium Bicarb 8.4% 50 mL SDV, c) Sodium Bicarbonate 8.4%, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "product_quantity": "6213 vials", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "recall_initiation_date": "20130410", "center_classification_date": "20130516", "termination_date": "20140321", "report_date": "20130522", "code_info": "Lot #: Sodium Bicarb 4.2% 5 mL PF: 130123150AE, Exp 4/23/2013; b) Sodium Bicarb 8.4% 50 mL SDV: 20130315-L, Exp 6/15/2013; c) Sodium Bicarbonate 8.4%: 20130117-D, Exp 4/17/2013; 20130117-E, Exp 4/17/2013; 20130117-F, Exp 4/17/2013; 20130121-B, Exp 4/21/2013; 20130121-C, Exp 4/21/2013; 20130121-D, Exp 4/21/2013; 20130121-E, Exp 4/21/2013; 20130121-F, Exp 4/21/2013; 20130121-H, Exp 4/21/2013; 20130121-I, Exp 4/21/2013; 20130121-J, Exp 4/21/2013; 20130121-K, Exp  4/21/2013; 20130124-D, Exp 4/24/2013; 20130124-E, Exp 4/24/2013; 20130129-B, Exp 4/29/2013; 20130129-C, Exp 4/29/2013; 20130129-D, Exp 4/29/2013; 20130129-K, Exp 4/29/2013; 20130129-L, Exp 4/29/2013; 20130129-M, Exp  4/29/2013; 20130131-I, Exp 4/30/2013; 20130131-J, Exp  4/30/2013; 20130131-K, Exp 4/30/2013; 20130201-B, Exp 5/1/2013; 20130201-C, Exp  5/1/2013; 20130211-A, Exp  5/11/2013; 20130211-B, Exp  5/11/2013; 20130211-C, Exp 5/11/2013; 20130211-D, Exp 5/11/2013; 20130211-E, Exp  5/11/2013; 20130211-F, Exp 5/11/2013; 20130211-G, Exp  5/11/2013; 20130211-H, Exp 5/11/2013; 20130211-I, Exp 5/11/2013; 20130211-J, Exp 5/11/2013; 20130211-K, Exp 5/11/2013; 20130211-L, Exp 5/11/2013; 20130211-N, Exp 5/11/2013; 20130211-O, Exp 5/11/2013; 20130211-P, Exp 5/11/2013; 20130211-Q, Exp 5/11/2013; 20130211-R, Exp 5/11/2013; 20130211-S, Exp 5/11/2013; 20130211-T, Exp 5/11/2013; 20130214-D, Exp 5/14/2013; 20130214-E, Exp 5/14/2013; 20130214-H, Exp 5/14/2013; 20130215-A, Exp 5/15/2013; 20130215-B, Exp 5/15/2013; 20130215-D, Exp 5/15/2013; 20130215-E, Exp 5/15/2013; 20130215-G, Exp 5/15/2013; 20130215-H, Exp 5/15/2013; 13021840GV3, Exp 5/18/2013; 20130219-G, Exp 5/19/2013; 20130219-H, Exp 5/19/2013; 20130219-I, Exp 5/19/2013; 20130219-J, Exp 5/19/2013; 20130221-B, Exp 5/21/2013; 20130221-A, Exp 5/21/2013; 20130221-E, Exp 5/21/2013; 20130221-F, Exp 5/21/2013; 20130221-G, Exp 5/21/2013; 20130221-H, Exp 5/21/2013; 20130221-P, Exp 5/21/2013; 20130221-Q, Exp 5/21/2013; 20130221-S, Exp 5/21/2013; 20130222-B, Exp 5/22/2013; 20130222-C, Exp 5/22/2013; 20130225-E, Exp 5/25/2013; 20130225-F, Exp 5/25/2013; 20130225-G, Exp 5/25/2013; 201302256-GV4, Exp 5/25/2013; 20130227-P, Exp 5/27/2013; 20130227-Q, Exp 5/27/2013; 20130227-R, Exp 5/27/2013; 20130227-S, Exp 5/27/2013; 20130227-T, Exp 5/27/2013; 20130228-F, Exp 5/28/2013; 20130228-G, Exp 5/28/2013; 20130204-I, Exp 5/4/2013; 20130205-D, Exp 5/5/2013; 20130205-E, Exp 5/5/2013; 20130205-F, Exp 5/5/2013; 20130206-E, Exp 5/6/2013; 20130206-F, Exp 5/6/2013; 20130206-I, Exp 5/6/2013; 20130206-J, Exp 5/6/2013; 20130206-K, Exp 5/6/2013; 20130206-L, Exp 5/6/2013; 20130207-C, Exp 5/7/2013; 20130207-D, Exp 5/7/2013; 20130207-E, Exp 5/7/2013; 20130301-B, Exp 6/1/2013; 20130312-A, Exp 6/12/2013; 20130312-B, Exp 6/12/2013; 20130312-C, Exp 6/12/2013; 20130312-D, Exp 6/12/2013; 13031240GV4, Exp 6/12/2013; 20130313-J, Exp 6/13/2013; 20130313-K, Exp 6/13/2013; 20130314-G, Exp 6/14/2013; 20130314-L, Exp 6/14/2013; 20130314-M, Exp 6/14/2013; 20130315-L, Exp 6/15/2013; 20130315-M, Exp 6/15/2013; 20130315-N, Exp 6/15/2013; 20130318-H, Exp 6/18/2013; 20130319-D, Exp 6/19/2013; 20130319-K, Exp 6/19/2013; 20130319-L, Exp 6/19/2013; 20130320-G, Exp 6/20/2013; 20130320-H, Exp 6/20/2013; 20130320-I, Exp 6/20/2013; 20130320-J, Exp 6/20/2013; 20130320-K, Exp 6/20/2013; 20130320-L, Exp 6/20/2013; 20130325-I, Exp 6/25/2013; 20130325-J, Exp 6/25/2013; 20130325-L, Exp 6/25/2013; 20130325-M, Exp 6/25/2013; 20130325-N, Exp 6/25/2013; 20130327-D, Exp 6/27/2013; 20130327-E, Exp 6/27/2013; 20130327-F, Exp 6/27/2013; 20130327-G, Exp 6/27/2013; 20130327-H, Exp 6/27/2013; 20130327-I, Exp 6/27/2013; 20130327-J, Exp 6/27/2013; 20130327-K, Exp 6/27/2013; 20130327-L, Exp 6/27/2013; 20130327-M, Exp 6/27/2013; 20130327-N, Exp 6/27/2013; 20130329-D, Exp 6/29/2013; 20130329-E, Exp 6/29/2013; 20130329-F, Exp 6/29/2013; 20130329-G, Exp 6/29/2013; 20130304-B, Exp 6/4/2013; 20130304-C, Exp 6/4/2013; 20130304-D, Exp 6/4/2013; 20130304-E, Exp 6/4/2013; 20130304-F, Exp 6/4/2013; 20130304-G, Exp 6/4/2013; 20130304-H, Exp 6/4/2013; 20130304-I, Exp 6/4/2013; 20130306-A, Exp 6/6/2013; 20130306-B, Exp 6/6/2013; 20130306-C, Exp 6/6/2013; 20130306-D, Exp 6/6/2013; 20130306-I, Exp 6/6/2013; 20130306-J, Exp 6/6/2013; 20130306-K, Exp 6/6/2013; 20130308-A, Exp 6/8/2013; 20130308-B, Exp 6/8/2013; 20130308-C, Exp 6/8/2013; 20130308-D, Exp 6/8/2013; 20130308-E, Exp 6/8/2013; 20130308-F, Exp 6/8/2013; 20130401-D, Exp 7/1/2013; 20130401-E, Exp 7/1/2013; 20130401-F, Exp 7/1/2013; 20130404-B, Exp 7/4/2013; 20130404-C, Exp 7/4/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["EXCHANGE SELECT ALLER EASE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Army & Air Force Exchange Service"], "product_ndc": ["55301-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["90602f30-0627-446f-bd62-4dc80ead187d"], "spl_set_id": ["6a9597a1-f024-4497-bc52-3d5482758822"], "package_ndc": ["55301-847-39"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0904-2023", "product_description": "aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Packaged For: Your Military Exchanges, By: Perrigo Company, Allegan, MI USA 49010. NDC 55301-847-39", "product_quantity": "1,920 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2ER0285,Exp. date 01/24", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA075784"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-161", "63323-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ab476c4c-2c72-47b1-bf42-7a89703b0dd4"], "spl_set_id": ["d1920335-8e45-4960-b6e9-e6f1f9e6820c"], "package_ndc": ["63323-161-00", "63323-161-01", "63323-162-11", "63323-162-51", "63323-162-00", "63323-162-01", "63323-162-03", "63323-162-02"], "is_original_packager": [true], "upc": ["0363323162115", "0363323161002", "0363323162009", "0363323162030"], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "87082", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0245-2021", "product_description": "Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.", "product_quantity": "945,425 vials", "reason_for_recall": "Presence of Particulate Matter - found in reserve sample vials at the firm.", "recall_initiation_date": "20201223", "center_classification_date": "20210127", "termination_date": "20230609", "report_date": "20210203", "code_info": "Lot # 6121083, Exp 2/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078281"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["62175-617", "62175-180", "62175-618"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["251872", "314200"], "spl_id": ["cfbf12d8-f656-4b99-bd2e-fb11bab669e5"], "spl_set_id": ["e7705bf6-e473-4b9c-bb5d-57e26ffe7b97"], "package_ndc": ["62175-617-46", "62175-617-43", "62175-180-46", "62175-180-43", "62175-618-46", "62175-618-43"], "is_original_packager": [true], "upc": ["0362175617460", "0362175180469"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0506-2021", "product_description": "Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg* 90 Tablets Rx Only NDC 62175-180-46 Distributed by: Kremers Urban Pharmaceuticals Inc. Princeton, NJ 08540, USA", "product_quantity": "4 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20249489A"}, {"status": "Terminated", "city": "Pacific Palisades", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA213312"], "brand_name": ["FYARRO"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["Aadi Bioscience"], "product_ndc": ["80803-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SIROLIMUS"], "rxcui": ["2586863", "2586868"], "spl_id": ["5cc321b2-bc32-443d-b334-8b8752a673c5"], "spl_set_id": ["0f9bb784-53e2-46f9-a65d-1c6c2a230eaf"], "package_ndc": ["80803-153-50"], "is_original_packager": [true], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "91019", "recalling_firm": "Aadi Bioscience", "address_1": "17383 W Sunset Blvd Ste A250", "address_2": "N/A", "postal_code": "90272-4181", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the U.S Market - PA, AL, KY, TN", "recall_number": "D-0059-2023", "product_description": "Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.", "product_quantity": "2,333 vials", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20221013", "center_classification_date": "20221114", "termination_date": "20230316", "report_date": "20221123", "code_info": "Lot# 6025701, Expiration Date: 31MAR2023, 100mg/vial, 50 ml single use vial, NDC 80803-153-50."}]